Возможность использования продуктов эмбриофетоплацентарного комплекса как корректора апоптотических процессов при аутоиммунных заболеваниях

• Date: 2003
• Main Authors: Goltsev, A. N., Grischenko, V. I., Rassokha, I. V., Ostankov, M. V.
• Format: Article
• Language: English
• Published: Publishing House ‘Akademperiodyka’ of the National Academy of Sciences of Ukraine; Institute for Problems of Cryobiology and Cryomedicine 2003
• Subjects: апоптоз; ревматоїдний артрит; продукти ембріофетоплацентарного комплексу
• Online Access: https://cryo.org.ua/journal/index.php/probl-cryobiol-cryomed/article/view/1077
• Journal Title: Problems of Cryobiology and Cryomedicine

The authors have studied the activity of immune competent cells in an experimental model of rheumatoid arthritis in mice. There was demonstrated the possibility to apply the products of embryo fetoplacental complex (PEFPC) to modulate the apoptotic processes under autoimmune diseases (AIDs).